201 related articles for article (PubMed ID: 7683626)
1. Do haemopoietic growth factors increase the efficacy of aggressive therapy of ANLL in elderly patients?
Mandelli F; Petti MC
Hematol Oncol; 1993; 11 Suppl 1():9-11. PubMed ID: 7683626
[No Abstract] [Full Text] [Related]
2. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
3. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
de la Rubia Comos J
Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
[No Abstract] [Full Text] [Related]
4. [Clinical use of hematopoietic growth factors].
Robak T
Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
[No Abstract] [Full Text] [Related]
5. Treatment of myelodysplastic syndromes with hemopoietic growth factors.
Greenberg PL
Semin Oncol; 1992 Feb; 19(1):106-14. PubMed ID: 1371018
[No Abstract] [Full Text] [Related]
6. The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.
Rossi Ferrini P; Santini V; Ciolli S; Grossi A; Leoni F; Rafanelli D; Vannucchi AM
Hematol Oncol; 1993; 11 Suppl 1():32-5. PubMed ID: 7683622
[No Abstract] [Full Text] [Related]
7. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
Ganser A; Hoelzer D
Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
[No Abstract] [Full Text] [Related]
8. Treatment of acute myelogenous leukaemia.
Löwenberg B
J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic growth factors in cancer chemotherapy.
Morstyn G; Foote M; Lieschke GJ
Cancer Chemother Biol Response Modif; 1996; 16():295-314. PubMed ID: 8639388
[No Abstract] [Full Text] [Related]
10. [Current status of the clinical application of hematopoietic growth factors in oncology].
Karthaus M; Ganser A
Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
[TBL] [Abstract][Full Text] [Related]
11. Disappointments in treating acute leukemia in the elderly.
Hamblin TJ
N Engl J Med; 1995 Jun; 332(25):1712-3. PubMed ID: 7539110
[No Abstract] [Full Text] [Related]
12. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor: present use and future directions.
Shadduck RK
Semin Hematol; 1992 Oct; 29(4 Suppl 3):38-42. PubMed ID: 1492233
[No Abstract] [Full Text] [Related]
14. [Clinical use of hematopoietic growth factors].
Krusius T
Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
[No Abstract] [Full Text] [Related]
15. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
Meng FY; Xu B; Sun J; Yang Y; Niu JN
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic growth factors and the future of therapeutic research on acute myeloid leukemia.
Schiffer CA
N Engl J Med; 2003 Aug; 349(8):727-9. PubMed ID: 12930923
[No Abstract] [Full Text] [Related]
17. [Clinical use of hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
Tóthová E
Vnitr Lek; 1998 Jun; 44(6):373-7. PubMed ID: 9820064
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic growth factors in autologous bone marrow transplantation.
Miller AM
Semin Oncol; 1993 Oct; 20(5 Suppl 6):88-95. PubMed ID: 7692607
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietins in combination with 1-beta-D-arabinofuranosylcytosine: a possible strategy for improved treatment of myeloid disorders.
Brach MA; Mertelsmann RH; Herrmann F
Semin Oncol; 1992 Apr; 19(2 Suppl 4):25-30. PubMed ID: 1372763
[TBL] [Abstract][Full Text] [Related]
20. [Hematopoietic growth factors. Current status of therapy].
Hiddemann W
Internist (Berl); 1994 Apr; 35(4):395-400. PubMed ID: 7515381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
